ASSEMBLY BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q3 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Assembly Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2013 to Q3 2024.
  • Assembly Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 251 %, a 1074% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 251 +230 +1074% Sep 30, 2024
Q2 2024 182 +162 +803% Jun 30, 2024
Q1 2024 120 +101 +546% Mar 31, 2024
Q4 2023 62.5 +46.3 +287% Dec 31, 2023
Q3 2023 21.4 +7.27 +51.4% Sep 30, 2023
Q2 2023 20.2 +7.87 +63.9% Jun 30, 2023
Q1 2023 18.6 +6.57 +54.7% Mar 31, 2023
Q4 2022 16.2 +3.73 +30% Dec 31, 2022
Q3 2022 14.1 +0.48 +3.51% Sep 30, 2022
Q2 2022 12.3 -1.86 -13.1% Jun 30, 2022
Q1 2022 12 -1.42 -10.6% Mar 31, 2022
Q4 2021 12.4 -3.85 -23.7% Dec 31, 2021
Q3 2021 13.7 -4.38 -24.3% Sep 30, 2021
Q2 2021 14.2 -9.3 -39.6% Jun 30, 2021
Q1 2021 13.4 -17.2 -56.1% Mar 31, 2021
Q4 2020 16.3 -17.6 -51.9% Dec 31, 2020
Q3 2020 18 -17.5 -49.2% Sep 30, 2020
Q2 2020 23.5 -7.14 -23.3% Jun 30, 2020
Q1 2020 30.6 -1.81 -5.59% Mar 31, 2020
Q4 2019 33.9 -0.63 -1.83% Dec 31, 2019
Q3 2019 35.5 -5.08 -12.5% Sep 30, 2019
Q2 2019 30.6 -34.3 -52.8% Jun 30, 2019
Q1 2019 32.4 -43.2 -57.1% Mar 31, 2019
Q4 2018 34.5 -54.7 -61.3% Dec 31, 2018
Q3 2018 40.6 -45.4 -52.8% Sep 30, 2018
Q2 2018 64.9 +7.17 +12.4% Jun 30, 2018
Q1 2018 75.6 +40 +112% Mar 31, 2018
Q4 2017 89.2 +71 +390% Dec 31, 2017
Q3 2017 85.9 +70.2 +446% Sep 30, 2017
Q2 2017 57.7 +44.3 +329% Jun 30, 2017
Q1 2017 35.6 +23.5 +196% Mar 31, 2017
Q4 2016 18.2 +6.83 +60.1% Dec 31, 2016
Q3 2016 15.7 +3.35 +27% Sep 30, 2016
Q2 2016 13.5 -1.33 -9% Jun 30, 2016
Q1 2016 12 -4.34 -26.5% Mar 31, 2016
Q4 2015 11.4 -8.01 -41.3% Dec 31, 2015
Q3 2015 12.4 -4 -24.4% Sep 30, 2015
Q2 2015 14.8 +6.68 +82.4% Jun 30, 2015
Q1 2015 16.4 +8.04 +96.5% Mar 31, 2015
Q4 2014 19.4 +11.5 +146% Dec 31, 2014
Q3 2014 16.4 +7.96 +94.3% Sep 30, 2014
Q2 2014 8.11 Jun 30, 2014
Q1 2014 8.33 Mar 31, 2014
Q4 2013 7.88 Dec 31, 2013
Q3 2013 8.44 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.